In millions, except per share items | Jun-30-23 | Mar-31-23 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 | Mar-31-21 |
| 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q |
Interest income: |
Interest income on loans | 3.5 | 3.3 | 2.9 | 3.0 | 3.1 | 3.2 | 3.1 | 3.1 |
Interest income on investments | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.2 |
| 3.9 | 3.8 | 3.2 | 3.2 | 3.4 | 3.5 | 3.4 | 3.3 |
Interest expense: |
Interest on deposits | 1.4 | 1.1 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 |
| 1.6 | 1.2 | 0.3 | 0.4 | 0.4 | 0.4 | 0.4 | 0.5 |
Net interest income | 2.2 | 2.5 | 2.8 | 2.9 | 3.0 | 3.1 | 2.9 | 2.8 |
Provision for loan losses | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 |
Net interest income after provision for loan losses | 2.1 | 2.4 | 2.7 | 2.7 | 2.9 | 3.0 | 2.8 | 2.7 |
Deposit and loan fees | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
Gain on sale of investments, net | | | | | 0.0 | 0.0 | 0.0 | |
Other non-interest income | 0.4 | 0.7 | 0.7 | 0.8 | 0.9 | 0.9 | 1.0 | 0.9 |
Total non-interest income | 0.8 | 1.3 | 1.3 | 1.3 | 1.4 | 1.5 | 1.5 | 1.4 |
Non-interest expenses | 3.1 | 3.1 | 2.8 | 2.9 | 3.0 | 3.5 | 3.1 | 2.9 |
Pre-tax income before non-recurring items | 0.1 | -0.2 | 0.4 | 0.5 | 0.6 | 0.5 | 0.4 | 0.4 |
Non-recurring items | 0.3 | | | | | | | |
Asset impairment | | | | | | 0.3 | | |
Pre-tax income | -0.2 | -0.2 | 0.4 | 0.5 | 0.6 | 0.2 | 0.4 | 0.4 |
Income taxes | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 |
Tax rate | 21.7% | 20.8% | 16.3% | 15.9% | 15.1% | 16.0% | 17.6% | 18.3% |
Net income | -0.2 | -0.2 | 0.3 | 0.4 | 0.5 | 0.2 | 0.4 | 0.4 |
Net margin | -5.8% | -4.2% | 8.8% | 9.7% | 12.2% | 3.9% | 8.6% | 8.7% |
|
Basic EPS | ($0.07) | ($0.07) | $0.15 | $0.17 | $0.22 | $0.07 | $0.16 | $0.15 |
Diluted EPS | ($0.07) | ($0.07) | $0.15 | $0.17 | $0.22 | $0.07 | $0.16 | $0.15 |
|
Shares outstanding (basic) | 2.2 | 2.2 | 2.3 | 2.4 | 2.4 | 2.3 | 2.3 | 2.4 |
Shares outstanding (diluted) | 2.2 | 2.2 | 2.3 | 2.4 | 2.4 | 2.3 | 2.3 | 2.4 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |